B, M., X, L., M, H., A, S. E., JY, L., D, B., . . . W, H. (2024). Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting. Frontiers in oncology, 14, 1395502. https://doi.org/10.3389/fonc.2024.1395502
Chicago Style (17th ed.) CitationB, Moloney, et al. "Initial Experience in Implementing Quantitative DCE-MRI to Predict Breast Cancer Therapy Response in a Multi-center and Multi-vendor Platform Setting." Frontiers in Oncology 14 (2024): 1395502. https://doi.org/10.3389/fonc.2024.1395502.
MLA (9th ed.) CitationB, Moloney, et al. "Initial Experience in Implementing Quantitative DCE-MRI to Predict Breast Cancer Therapy Response in a Multi-center and Multi-vendor Platform Setting." Frontiers in Oncology, vol. 14, 2024, p. 1395502, https://doi.org/10.3389/fonc.2024.1395502.